methylprednisolone has been researched along with Dysautonomia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Kataria, S; Khan, E; Kramer, J; Moreno-Escobar, MC; Niaze, F; Peshwe, K; Sriwastava, S; Subedi, R; Tandon, M | 1 |
Finsterer, J | 1 |
Hunter, AJ; Ketterer, B; Montanaro, A | 1 |
Fabien, N; Hantson, P; Kevers, L; Van Den Bergh, P | 1 |
1 review(s) available for methylprednisolone and Dysautonomia
Article | Year |
---|---|
Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature.
Topics: Adult; Anti-Inflammatory Agents; Bromocriptine; COVID-19; Dopamine Agonists; Humans; Male; Methylprednisolone; Myelitis, Transverse; Primary Dysautonomias; SARS-CoV-2; Spinal Cord | 2021 |
3 other study(ies) available for methylprednisolone and Dysautonomia
Article | Year |
---|---|
Steroid-responsive, transverse myelitis is a known complication of COVID-19.
Topics: COVID-19; Humans; Methylprednisolone; Myelitis, Transverse; Primary Dysautonomias; SARS-CoV-2 | 2021 |
So Much More than Bald and Bloated.
Topics: Abdominal Pain; Adult; Humans; Immunoglobulins; Immunologic Factors; Male; Methylprednisolone; Nausea; Plasmapheresis; Primary Dysautonomias; Rituximab | 2018 |
Acute-onset chronic inflammatory demyelinating polyneuropathy with cranial nerve involvement, dysautonomia, respiratory failure, and autoantibodies.
Topics: Adult; Anti-Inflammatory Agents; Autoantibodies; Cranial Nerve Diseases; Diagnosis, Differential; Disease-Free Survival; Electrodiagnosis; Female; Guillain-Barre Syndrome; Humans; Immunoglobulins, Intravenous; Lupus Erythematosus, Systemic; Methylprednisolone; Neural Conduction; Plasma Exchange; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Primary Dysautonomias; Quadriplegia; Respiration, Artificial; Respiratory Insufficiency; Treatment Outcome | 2010 |